Cargando…

Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer

BACKGROUND: Current diagnosis tools for prostate cancer (PCa) such as serum PSA detection and prostate biopsy cannot distinguish dormant tumors from invasive malignancies, either be used as prognosis marker for castration resistant prostate cancer (CRPC), the lethal stage of PCa patients. Exosomes h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Pengyu, Wang, Wenxuan, Wang, Fei, Fan, Jiaqi, Guo, Jinan, Wu, Tao, Lu, Dongliang, Zhou, Qingchun, Liu, Zhuohao, Wang, Yuliang, Shang, Zhiqun, Chan, Franky Leung, Yang, Wei, Li, Xin, Zhao, Shan-Chao, Zheng, Qingyou, Wu, Dinglan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867857/ https://www.ncbi.nlm.nih.gov/pubmed/36681849 http://dx.doi.org/10.1186/s12967-022-03860-3

Ejemplares similares

A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer
por: Wang, Yuliang, et al.
Publicado: (2022)

Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer
por: Zhou, Jianfu, et al.
Publicado: (2021)

Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence
por: Wang, Zhu, et al.
Publicado: (2019)

Correction: Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence
por: Wang, Zhu, et al.
Publicado: (2020)

Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
por: Jia, Lin, et al.
Publicado: (2018)

Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer
por: Xu, Zhenyu, et al.
Publicado: (2018)

Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells
por: Wang, Zhu, et al.
Publicado: (2020)

Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis
por: Xu, Zhenyu, et al.
Publicado: (2020)

Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells
por: Gao, Weijie, et al.
Publicado: (2018)

Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells
por: Gao, Weijie, et al.
Publicado: (2022)

Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer
por: Wang, Wenxuan, et al.
Publicado: (2022)

Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis
por: Guo, Zhenlang, et al.
Publicado: (2019)

Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma
por: Zhou, Jiayi, et al.
Publicado: (2021)

Neutrophil–lymphocyte ratio is a predictor of prognosis in patients with castration-resistant prostate cancer: a meta-analysis
por: Wang, Zhun, et al.
Publicado: (2018)

HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer
por: Zhu, Shimiao, et al.
Publicado: (2023)

Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin
por: Liu, Zhuohao, et al.
Publicado: (2020)

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm
por: Zhou, Jianfu, et al.
Publicado: (2020)

In Vitro and In Vivo Antitumor Activity of Cucurbitacin C, a Novel Natural Product From Cucumber
por: Wu, Dinglan, et al.
Publicado: (2019)

YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth
por: Jiang, Ning, et al.
Publicado: (2017)

Concomitant protein pathogenesis in Parkinson’s disease and perspective mechanisms
por: Han, Yuliang, et al.
Publicado: (2023)

Urinary exosome-based androgen receptor-variant 7 detection in metastatic castration-resistant prostate cancer patients
por: Wang, Chao, et al.
Publicado: (2022)

Exosomal miR‐222‐3p contributes to castration‐resistant prostate cancer by activating mTOR signaling
por: Wang, Weixi, et al.
Publicado: (2023)

Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3
por: Chen, Xuanrong, et al.
Publicado: (2021)

AB007. Neurotensin derived from cancer stroma contributes to castration resistance via promoting neuroendocrine transdifferentiation
por: Zhu, Shimiao, et al.
Publicado: (2016)

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
por: Ge, Jianchao, et al.
Publicado: (2021)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

IL1 genes polymorphism and the risk of renal cell carcinoma in Chinese Han population
por: Wang, Fei, et al.
Publicado: (2017)

ADSCs-derived exosomes ameliorate hepatic fibrosis by suppressing stellate cell activation and remodeling hepatocellular glutamine synthetase-mediated glutamine and ammonia homeostasis
por: Wu, Baitong, et al.
Publicado: (2022)

The Identification of Plasma Exosomal miR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Development by Plasma Exosomal miRNA Sequencing
por: Guo, Tianyu, et al.
Publicado: (2021)

Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone
por: Zhu, Sha, et al.
Publicado: (2021)

Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma
por: Cao, Bingji, et al.
Publicado: (2021)

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma
por: Liu, Zhuohao, et al.
Publicado: (2023)

The application of polypropylene mesh for testicular prosthesis in surgical castration for patients with prostate cancer
por: Xia, Yao-Hui, et al.
Publicado: (2019)

Targeting castration-resistant prostate cancer with a novel RORγ antagonist elaiophylin
por: Zheng, Jianwei, et al.
Publicado: (2020)

Role of exosomal small RNA in prostate cancer metastasis
por: Zhan, Fei, et al.
Publicado: (2018)

LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21
por: Xiao, Lijia, et al.
Publicado: (2018)

Biohybrid materials: Structure design and biomedical applications
por: Wang, Chong, et al.
Publicado: (2022)

DNA–Polyelectrolyte Composite Responsive Microparticles for Versatile Chemotherapeutics Cleaning
por: Wang, Chong, et al.
Publicado: (2023)

Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122
por: Cong, Xiaonan, et al.
Publicado: (2021)

Exosomal ANXA1 derived from thyroid cancer cells is associated with malignant transformation of human thyroid follicular epithelial cells by promoting cell proliferation
por: Li, Qingchun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7f4vgeqmb4ask7h1l1guto30ao